
International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 3
May-June 2025
Indexing Partners



















In-Silico Analysis and Molecular Docking of Phytochemicals Targeting Genes as Therapeutic Sites for Prostate Cancer
Author(s) | Gayatree Pradhan, Debasmita Roy, Dharitri Priyadarsini, Rajat Kumar Nayak |
---|---|
Country | India |
Abstract | Prostate carcinoma is known to be a hypoxic and lipogenic solid tumor, exhibiting a remarkable oncogenic modulated metabolic programming. Increasing intake of glucose and aerobic glycolysis, called the Warburg effect, are main metabolic changes in hypoxic tumors. Protein, nucleic acid, and lipid biosynthesis are the other metabolic processes associated with cancer metabolic rewiring. Research on new treatments and prevention strategies for prostate cancer has increased due to the disease's rising occurrence globally. Broccoli and other plants of the Brassica genus contain sulforaphane, a phytochemical with anticancer qualities. Several investigations have demonstrated that sulforaphane stops prostate cancers from growing and spreading. This study assesses the most current research on sulforaphane's ability to stop prostate cancer from progressing in vitro, in vivo, and in clinical settings along with Genistein and Silibinin. The suggested methods of action of sulforaphane on prostatic cells are described in depth. We also go over the difficulties, restrictions, and potential applications of sulforaphane as a therapeutic agent in the management of prostate cancer. Molecular docking was held between the compounds and the genes associated with prostate cancer: PDGFRA, PDGFRB, GSTP1, GPX2, GPX3 and MGST2. Using several techniques, this brief in silico analysis revealed notable diversity in the prediction of SFN's physicochemical and pharmacokinetic properties as well as its toxicological potential. Even though SFN showed a strong potential to prevent metastases in several tumor models, further extensive in silico and toxicity studies are required to fully investigate its toxicological profile. |
Keywords | Sulforaphane, Genistein, Silibinin, Prostate, Drug likeness, Phytochemicals, PDGFRA, PDGFRB, GSTP1, GPX2, GPX3 and MGST2 |
Field | Biology > Bio + Chemistry |
Published In | Volume 7, Issue 2, March-April 2025 |
Published On | 2025-04-26 |
DOI | https://doi.org/10.36948/ijfmr.2025.v07i02.42185 |
Short DOI | https://doi.org/g9gvc5 |
Share this

E-ISSN 2582-2160

CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
